Understanding how bacteria control protein synthesis quality
Structural bases for protein synthesis quality control
This study looks at how tiny parts of bacteria help make proteins correctly, which is important for their survival, and it aims to find new ways to create antibiotics that can better fight off tough bacterial infections, ultimately helping patients get better treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project ID | NIH-11090094 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which bacterial ribosomes ensure the accuracy of protein synthesis, which is crucial for gene expression. It focuses on the role of specific translation factors that help monitor and correct errors during this process. By exploring how these factors interact with ribosomes, the research aims to uncover new strategies for developing antibiotics that can effectively combat antibiotic-resistant bacteria. Patients may benefit from improved treatments for bacterial infections as a result of this work.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients suffering from bacterial infections, particularly those caused by antibiotic-resistant strains.
Not a fit: Patients with viral infections or those who do not have bacterial infections may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antibiotics that are effective against resistant bacterial infections.
How similar studies have performed: Other research has shown promise in understanding ribosomal function and its implications for antibiotic development, indicating that this approach could yield significant advancements.
Where this research is happening
Galveston, United States
- University of Texas Med Br Galveston — Galveston, United States (Active)
Researchers
- Principal investigator: Gagnon, Matthieu — University of Texas Med Br Galveston
- Study coordinator: Gagnon, Matthieu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.